Accreditation Statements

• DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 3.75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and Iowa Chapter American Academy of Pediatrics. DMU designates this live activity for 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Nurses: Des Moines University Medicine and Health Sciences has determined that this activity meets the requirements for 3.75 contact hours as defined by the Iowa Board of Nursing and Iowa Administrative Code 481-619.
• Other healthcare providers: This activity is designated for 3.75 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

Disclosures

The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The activity director determines the educational content and selects speakers. 

Relevant to the content of this educational activity, the following individuals have no conflict(s) with ineligible companies to disclose.

• Nathan Boonstra, MD, FAAP - Speaker
• Ashleigh Burt, MD, FAAP - Planning Committee Member
• Dinah Conti, MD, FAAP - Moderator
• Meredith Fishbane-Gordon, MD, FAAP - Planning Committee Member and Speaker
• Burgundy Johnson, DO - Speaker
• Rabia Khan, MD, FAAP - Planning Committee Member
• Sujana Madathil, MBBS, MHSc - Speaker
• Jessie Marks, MD, FAAP - Planning Committee Member and Speaker
• Jason Misurac, MD, MS - Speaker
• Abimbola Olayinka, MD, FAAP - Planning Committee Member
• Ana Maria Quintero Nunes, MD, FAAP - Speaker
• Kelly Pelzel, PhD - Speaker
• Kristina Seier, LMSW - Activity Director
• Amy Shriver, MD, FAAP - Planning Committee Member
• Julie Stecher, MD, FAAP - Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated through peer review by individuals with no relevant financial relationships or through attestation to evidence-based clinical guidelines.

• Gabriel Castano-Heredia, MD, FAAP - Speaker
  • Naevan Health
    • Consultant
      • The financial relationship has not ended.
      • The financial relationship is relevant to the educational content.
      • Intends to discuss off-label uses of the following commercial product(s)/device(s) and agrees to inform learners of such.
• Ashlesha Kaushik, MD, MS, FAAP - Planning Committee Member
  • Merck
    • Speaker’s bureau
      • The financial relationship has not ended.
      • The financial relationship is not relevant to the educational content.
• Marianka Pille, MD, FAAP - Planning Committee Member
  • Eli Lilly
    • Self-managed stock shareholder
      • The financial relationship has not ended.
      • The financial relationship is not relevant to the educational content.
  • Johnson and Johnson
    • Self-managed stock shareholder
      • The financial relationship has not ended.
      • The financial relationship is not relevant to the educational content.
• Lukasz Weiner, MD, FAAP - Speaker
  • Shionogi
    • Grants or Research Support
      • The financial relationship ended in August 2025.
      • The financial relationship is not relevant to the educational content.

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.